v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Operating activities    
Net income (loss) $ 45,966 $ (105,050)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 75,522 56,423
Amortization of intangible assets 12,405 7,634
Amortization of deferred contract acquisition costs 98,856 102,903
Non-cash operating lease cost 4,927 4,186
Stock-based compensation expense 297,703 247,661
Deferred income taxes (10,831) (1,681)
Realized gains on strategic investments (36,362) 0
Non-cash interest expense 470 1,088
Change in fair value of strategic investments 0 1,579
Changes in operating assets and liabilities, net of impact of acquisitions    
Accounts receivable, net 428,834 319,871
Deferred contract acquisition costs (92,702) (102,803)
Prepaid expenses and other assets (74,992) (20,995)
Accounts payable (54,354) (83,228)
Accrued expenses and other liabilities (43,990) (43,763)
Accrued payroll and benefits (19,634) (37,848)
Operating lease liabilities (4,161) (4,586)
Deferred revenue (36,720) 42,716
Net cash provided by operating activities 590,937 384,107
Investing activities    
Purchases of property and equipment (97,624) (85,751)
Capitalized internal-use software and website development costs (22,571) (17,437)
Purchases of strategic investments (400) (374)
Proceeds from sales of strategic investments 10,197 3,146
Business acquisitions, net of cash and restricted cash acquired (881,376) 0
Purchases of deferred compensation investments (2,348) (1,459)
Proceeds from the sale of deferred compensation investments 69 45
Net cash used in investing activities (994,053) (101,830)
Financing activities    
Proceeds from issuance of common stock upon exercise of stock options 683 634
Distributions to non-controlling interest holders (20,952) 0
Capital contributions from non-controlling interest holders 0 1,500
Repurchases of common stock (175,622) 0
Net cash provided by (used in) financing activities (195,891) 2,134
Effect of foreign exchange rates on cash, cash equivalents and restricted cash 116 6,546
Net increase (decrease) in cash, cash equivalents and restricted cash (598,891) 290,957
Cash, cash equivalents and restricted cash at beginning of period 5,314,617 4,324,666
Cash, cash equivalents, and restricted cash 4,715,726 4,615,623
Cash and cash equivalents 4,552,801 4,614,153
Restricted cash included in prepaid expenses and other current assets 39,207 1,470
Restricted cash included in other long-term assets 123,718 0
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 4,715,726 4,615,623
Supplemental disclosure of cash flow information:    
Interest paid 11,250 11,250
Income taxes paid, net of refunds received 23,314 17,026
Supplemental disclosure of non-cash investing and financing activities:    
Net increase (decrease) in property and equipment included in accounts payable and accrued expenses 30,951 (32,212)
Equity consideration for acquisitions 22,949 0
Operating lease liabilities arising from obtaining operating right-of-use assets 4,398 0
Proceeds from sales of strategic investments not yet received 7,705 1,846
Stock-based compensation included in capitalized software development costs and fixed assets 15,832 13,291
Restricted cash held in escrow for purchase consideration for business combinations $ 74,000 $ 0